Brief: Dice Therapeutics Inc Initiates Phase 1 Clinical Trial Of S011806 For The Treatment Of Psoriasis
Oct 25 (Reuters) - Dice Therapeutics Inc DICE.O :
* DICE THERAPEUTICS INITIATES PHASE 1 CLINICAL TRIAL OF
S011806
FOR THE TREATMENT OF PSORIASIS
Source text for Eikon: ID:nGNX7GmY7T
Further company coverage: DICE.O
Recent news on Dice Therapeutics
See all newsBrief: Lilly Completes Acquisition Of Dice Therapeutics
Dice Therapeutics Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Eli Lilly Announces Extension Of Tender Offer To Acquire Dice
MoonLake Immunotherapeutics explores sale-sources
MoonLake Immunotherapeutics explores sale-sources